Menu
1. Bactéries dans le sang, antibiotiques par la bouche
2. Conflits d’intérêt
3. What percentage of antibiotic use at HUG is intravenous (as % of DDD)
4. % antibiotiques intraveineux (hôpitaux suisses > 500 lits)
5. Potential advantages of oral antimicrobial treatment
6. What adjective do you associate with intravenous (compared to oral) antibiotics
7. “Magical thinking” in infectious diseases
8. Les antibiotiques en IV : plus forts ?
9. Other ”magical” concepts ? Bacteriostatic versus bactericidal antibiotics
10. Are oral antibiotics as ”strong” as intravenous antibiotics for bacteremia due to Enterobacteriaceae?
11. A 41-year old patient has pyelonephritis with bacteremia due multisusceptible E. coli
12. PICOS : Population
13. PICOS : Population
14. PICOS : Intervention
15. PICOS : Control
16. PICOS : Outcome
17. PICOS : Setting
18. Eligibility criteria for oral step-down therapy
19. Methods
20. Baseline characteristics 4967 patients with Enterobacteriaceae bacteremia => 2161 patients met eligibility criteria => 1478 included in analysis
21. Baseline characteristics 4967 patients with Enterobacteriaceae bacteremia => 2161 patients met eligibility criteria => 1478 included in analysis
22. Source of bacteremia & species of Enterobacteriaceae
23. Source of bacteremia & species of Enterobacteriaceae
24. Antibiotics received
25. Résultats
26. Limitations
27. How surprised are you by the results ?
28. How comfortable would you feel to switch to oral antibiotics for
29. Partial Oral versus Intravenous antibiotic treatment of endocarditis
30. Conclusions: Oral antibiotic treatment for Gram negative bacteremia, or “proving the obvious”
31. Merci!
32. Thérapie orale vs IV
Bactéries dans le sang, antibiotiques dans la bouche, Dr B. Huttner, 29.10.19
Resources
Here are some useful links and documents:
Title
Title
Title
FINISH
SUBMIT
NEXT
PREV
Submit All